Lauren Osullivan, DO
Gynecology · Bend, ORNPI 1316983679
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $429 of the $514 with a category attached, or 83.5%. 9 manufacturers reported payments, led by AbbVie at 32.1% of the total. Reporting peaked in 2024 at $154 and has fallen 74.6% since, to $39 in 2025.
Across 22 payments — averaging $23.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$165
- Astellas Pharma US Inc$107
- Therapeuticsmd, Inc.$55
- Sumitomo Pharma America, Inc.$48
- Hologic Sales And Service, LLC$42
- Merck$30
- plus $68 from 3 others
What the payments were for
- Food & beverage$42983%
- Education$8517%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 4 | $165 |
| Astellas Pharma US Inc | 2 | $107 |
| Therapeuticsmd, Inc. | 3 | $55 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| Hologic Sales And Service, LLC | 3 | $42 |
| Merck | 2 | $30 |
| Organon | 4 | $27 |
| Exact Sciences | 1 | $24 |
| Vertex | 1 | $17 |
How this compares
$514 in reported general payments places this provider in the 60th percentile of 34 gynecology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 128 | $9,037 |
| EstringEstradiol | 17 | $8,802 |
| Clobetasol Propionate | 25 | $2,022 |
| ValacyclovirValacyclovir Hcl | 34 | $1,001 |
| Betamethasone Dipropionate | 20 | $842 |
| Gabapentin | 23 | $223 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Bend
- Maria EmersonBend$3K
- Ashley McClaryBend$1K
- Jane BirschbachBend$116
- Shanti MohlingPortland$50K
- Richard RosenfieldPortland$24K
- Terresa JungPortland$11K
- Elizabeth McCorkleEugene$7K
- Karina HoanPortland$4K
- Claire GouldPortland$3K
- Laura KormanPortland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.